Predicting immune responses to vaccination
Armed with a machine learning and systems biology approach, John Tsang studies how past infections and vaccinations shape an individual’s immune response to future vaccines.
Infectious Disease & Vaccines
Sniffing plasma helps COVID-19 patients smell again
People with COVID-19 sometimes lose their sense of smell. But a clinical researcher has a possible solution: the patient’s own blood.
Self-amplifying RNA may reduce side effects associated with RNA vaccines
Anna Blakney, an RNA bioengineer and TikTok science communicator, studies how self-amplifying RNA improves RNA vaccines and therapeutics.
Competition breeds ingenuity in translational research
It’s human nature to compare one’s success to others, but thinking that the grass is greener on the other side can be detrimental to one’s health. Recognizing strategies as equal but unique ways to tackle a common problem is a healthier perspective.
An infective spark for Alzheimer's disease
A once fringe theory that viral and bacterial infections trigger the neuroinflammation and cognitive decline associated with Alzheimer’s disease is gaining traction. If it proves true, available antimicrobials could be a long sought-after treatment for this neurodegenerative disease.
Gut microbes may predict the effectiveness of anthelminthic drugs
Pre-screening of the gut microbiome may lead to a more personalized approach to treating intestinal parasitic worm infections, leading to better treatment outcomes and a decreased risk for drug resistance.
Strategies for Detecting New Viral Threats
Learn how scientists detect viral pathogens lurking in the environment to mitigate infectious disease threats.
CRISPR for Vaccine Development
Discover a novel approach to vaccine discovery using CRISPR engineering.
New Hope for Malaria Vaccines
LIVE June 15th, 2022 at 1:30 PM
Newly designed malaria vaccines are bringing life-saving treatments to people around the world.
Newly designed malaria vaccines are bringing life-saving treatments to people around the world.
A pandemic lost in translation
As the science on vaccination and natural infection-based immunity against COVID-19 variants continues to evolve, accurately communicating study results and their limitations has never been more important.
